RATIOS
Panacea Biotec Ltd.
BSE
May 13, 01:35
535.00
+19.90 (+ 3.86%)
Volume
67150
Prev. Close
515.10
Open Price
522.00
Bid Price(Qty.)
534.90 (15)
Offer Pr.(Qty.)
535.50 (30)
NSE
May 13, 01:24
535.05
+21.40 (+ 4.17%)
Volume
415395
Prev. Close
513.65
Open Price
520.00
Bid Price(Qty.)
535.05 (270)
Offer Pr.(Qty.)
535.95 (1)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE922B01023
|
Market Cap. ( ₹ in Cr. )
|
3277.22
|
P/BV
|
3.93
|
Book Value ( ₹ )
|
135.98
|
|
BSE Code
|
531349
|
52 Week High/Low ( ₹ )
|
582/112
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
NSE Code
|
PANACEABIOEQ
|
Book Closure
|
27/09/2024
|
EPS ( ₹ )
|
0.00
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.58 | -14.29 | -15.28 | -2.35 | -24.99 |
| Diluted EPS (Rs.) | 0.58 | -14.29 | -15.28 | -2.35 | -24.99 |
| Cash EPS (Rs.) | 4.02 | -10.29 | -10.96 | 1.98 | -20.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 50.20 | 49.63 | 64.24 | 79.43 | 142.19 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 50.20 | 49.63 | 64.24 | 79.43 | 142.19 |
| Revenue From Operations / Share (Rs.) | 58.71 | 41.97 | 38.45 | 56.09 | 25.81 |
| PBDIT / Share (Rs.) | 6.38 | -4.60 | -9.81 | 3.47 | -5.12 |
| PBIT / Share (Rs.) | 2.94 | -8.60 | -14.13 | -0.87 | -9.51 |
| PBT / Share (Rs.) | 0.68 | -10.25 | -15.28 | -2.10 | -12.89 |
| Net Profit / Share (Rs.) | 0.57 | -14.29 | -15.28 | -2.36 | -24.99 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 10.86 | -10.96 | -25.52 | 6.18 | -19.83 |
| PBIT Margin (%) | 5.00 | -20.49 | -36.74 | -1.55 | -36.85 |
| PBT Margin (%) | 1.16 | -24.41 | -39.73 | -3.74 | -49.92 |
| Net Profit Margin (%) | 0.98 | -34.05 | -39.73 | -4.20 | -96.82 |
| Return on Networth / Equity (%) | 1.15 | -28.79 | -23.78 | -2.96 | -17.57 |
| Return on Capital Employeed (%) | 3.56 | -11.18 | -16.79 | -0.90 | -6.01 |
| Return On Assets (%) | 0.47 | -12.09 | -12.28 | -1.82 | -13.44 |
| Long Term Debt / Equity (X) | 0.38 | 0.32 | 0.20 | 0.12 | 0.06 |
| Total Debt / Equity (X) | 0.38 | 0.32 | 0.20 | 0.12 | 0.07 |
| Asset Turnover Ratio (%) | 0.48 | 0.34 | 0.30 | 0.35 | 0.12 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.73 | 0.81 | 1.17 | 1.46 | 3.60 |
| Quick Ratio (X) | 0.30 | 0.35 | 0.64 | 1.02 | 3.02 |
| Inventory Turnover Ratio (X) | 1.11 | 1.07 | 1.59 | 0.73 | 1.06 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 2.84 | -2.80 | -8.53 | 2.83 | -5.95 |
| Interest Coverage Ratio (Post Tax) (%) | 1.26 | -7.70 | -12.29 | -0.91 | -14.31 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 838.39 | 722.84 | 949.50 | 1059.69 | 674.08 |
| EV / Net Operating Revenue (X) | 2.33 | 2.81 | 4.03 | 3.08 | 4.26 |
| EV / EBITDA (X) | 21.46 | -25.64 | -15.80 | 49.90 | -21.50 |
| MarketCap / Net Operating Revenue (X) | 2.07 | 2.58 | 3.86 | 3.16 | 4.24 |
| Price / BV (X) | 2.42 | 2.18 | 2.31 | 2.23 | 0.77 |
| Price / Net Operating Revenue (X) | 2.07 | 2.58 | 3.86 | 3.16 | 4.24 |
| EarningsYield | 0.00 | -0.13 | -0.10 | -0.01 | -0.22 |